Macrolide resistance from the ribosome perspective

F Franceschi1, Z Kanyo, E C Sherer

  • 1Rib-X Pharmaceuticals, Inc., 300 George Street, Suite 301, New Haven, CT 06511, USA.

Current Drug Targets. Infectious Disorders
|September 24, 2004
PubMed

Insights

Macrolide antibiotics fight respiratory infections. Recent structural studies reveal how these drugs bind to bacterial ribosomes and how resistance develops at the molecular level.

Area of Science:

  • Molecular Biology
  • Microbiology
  • Pharmacology

Background:

  • Macrolides are crucial antibiotics for treating human respiratory tract infections.
  • Understanding their mechanism of action and resistance is vital, despite decades of use.

Purpose of the Study:

  • To compare the binding modes of various macrolides and ketolides to ribosomal subunits.
  • To elucidate the atomic-level details of antibiotic-ribosome interactions and resistance mechanisms.

Main Methods:

  • Structural resolution of macrolide and ketolide complexes with ribosomal 50S subunits from Haloarcula marismortui and Deinococcus radiodurans.
  • Comparative analysis of binding features at the atomic level.

Main Results:

  • Detailed comparison of binding characteristics for 14-, 15-, and 16-membered macrolides versus ketolides (telithromycin, ABT-773).
  • Insights into how modifications in 23S rRNA and ribosomal proteins L4/L22 confer resistance.

Conclusions:

  • Structural biology provides a detailed understanding of macrolide-ribosome interactions.
  • This knowledge is key to comprehending and potentially overcoming antibiotic resistance in key pathogens.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...